Ventricular arrhythmias in Kearns-Sayre syndrome: A cohort study using the National Inpatient Sample database 2016-2019.
Kyle WisemanDhairya GorNdausung UdongwoAbbas AlshamiVandan UpadhayaSteven J DanielsWendy K ChungCharles H KooPublished in: Pacing and clinical electrophysiology : PACE (2022)
Despite its effectiveness in preventing VA, PPM remains underutilized in patients with KSS or MD who have conduction abnormalities. PPM alone do not fully prevent VA in MD patients; therefore, addition of defibrillator capacity might be necessary.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- randomized controlled trial
- molecular dynamics
- heart failure
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- left ventricular
- emergency department
- quality improvement
- case report
- patient reported outcomes
- adverse drug
- atrial fibrillation
- patient reported
- cardiac resynchronization therapy
- electronic health record